Custom service

Peptide-Modified Liposome and LNP Delivery Services

Modify liposomes and lnps with peptides for targeted delivery

Turnaround: 5–10 weeksTypical scale: mg-scale construct plus validation reportChemistry options: post-insertion and pre-formulation peptide anchoring; ligand-density optimization; encapsulation-efficiency QC

Peptide-Modified Liposome and LNP Delivery Services supports programmes that modify liposomes and LNPs with peptides for targeted delivery. In a typical engagement we plan the post-insertion and pre-formulation peptide anchoring route first, confirm compatibility with ligand-density optimization, and release peptide-modified formulation with targeting and EE data on a 5–10 weeks schedule.

Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep post-insertion and pre-formulation peptide anchoring as the primary option and hold ligand-density optimization in reserve, so that scale-up never depends on an unproven step.

LNP targeting-ligand screening

Liposome surface engineering

Clinical-batch LNP manufacturing

In-vivo dosing campaigns without a completed in-vitro validation stage

Delivery programmes are released in two layers: chemical (identity, purity, payload loading) and functional (uptake, knockdown or transfection readout in the agreed cell model). Both layers are documented, because a construct that is chemically perfect but functionally silent is a failure.

Service Highlights

  • Post-insertion and pre-formulation peptide anchoring as the default route, with ligand-density optimization held as a proven fallback
  • Encapsulation-efficiency QC worked into the design where the application requires it
  • Every delivery construct is validated for uptake or knockdown function, not just characterized chemically
  • Analytical confirmation of every intermediate before the final release
  • Serum-stability and competitive-serum conditions are part of the standard test matrix
  • Peptide-modified formulation with targeting and EE data delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Payload & target review

    Payload chemistry, target cell and readout are agreed; Peptide-Modified Liposome and LNP Delivery Services concept routes are drafted.

  2. Construct design

    Peptide ligand, linker and presentation are designed; post-insertion and pre-formulation peptide anchoring is selected.

  3. Assembly

    The construct is assembled and purified chemically, with payload loading quantified.

  4. Functional validation

    Uptake or knockdown is measured in the target cell model, with ligand-density optimization controls.

  5. Stability & optimization

    Serum stability and iteration rounds tune the design to the agreed specification.

  6. Release & hand-off

    Peptide-modified formulation with targeting and EE data plus the validation report is released with a handling SOP.

Specifications & timeline

Turnaround
5–10 weeks
Typical scale
mg-scale construct plus validation report
Chemistry options
post-insertion and pre-formulation peptide anchoring; ligand-density optimization; encapsulation-efficiency QC
Deliverable
Peptide-modified formulation with targeting and EE data
QC package
Chemical QC plus functional uptake/delivery assay data
Shipping
Blue ice, aliquoted, with handling SOP

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.